NMDAr	N-methyl-D-Aspartate Receptor
SMA	Supplementary Motor Area
OFC	Orbitofrontal Cortex
PFc	Prefrontal Cortex
GABA-A	Gamma-Aminobutyric acid-A
NMDA	N-Methyl-D-Aspartate
CN	Caudate Nucleus
VS	Putamen and Ventral Striatum
iGP	Internal Globus Pallidus
eGP	ExternalGlobus Pallidus
SNc	Substantia Nigra Pars Compacta
SNr	Substantia Nigra Pars Reticulata
STN	Subthalamic Nucleus
VL	Ventral Lateral Nuclei of the Thalamus
VA	Ventral Anterior Nuclei of theThalamus
D1R	Dopamine Type 1 Receptor
D2R	Dopamine Type 2 Receptor
SCZ	Schizophrenia
vmPFC	Ventromedial Prefrontal Cortex
SPG	Superior Left Parietal Gyrus
SMG	Supramarginal Gyrus
MPF	Medial Prefrontal Cortex
CAC	Cingulate Anterior Cortex
NIC	Neuroleptic-Induced Catatonia
TNF alpha	Tumour Necrosis Factoralpha
NO	Nitric Oxide
Cnp	2’,3’- cyclic nucleotide 3’-phosphodiesterase
OS	Oxidative Stress
RS	Reactive Species
ROS	Reactive Oxygen Species
RNS	Reactive Nitrogen Species
H2O2	HydrogenPeroxide
ROO	Peroxyl Radicals
O2−O2−	Superoxide Anion Radical
OH	Hydroxyl Radical
ONOO-	Peroxynitrite
O2−	Single Molecular Oxygen
SOD	Superoxide Dismutase
GSH	Glutathione
RAGE	Receptor for Advanced Glycation End-Products
Nf-KB	Nuclear factor kappa-light-chain-enhancer ofactivated B cells
BBB	Blood-Brain Barrier
BZD	Benzodiazepines
ECT	Electroconvulsive Therapy
IM	Intramuscular
IST	Initial Seizure Threshold
rTMS	Repetitive Transmagnetic Stimulation
NMS	Neuroleptic Malignant Syndrome
CNS	Central Nervous System